Scarica l'app Stockscreener
1.88
2.59%
-0.05
Dopo l'orario di chiusura:
1.87
-0.010
-0.53%
Akebia Therapeutics Inc Borsa (AKBA) Ultime notizie
Akebia Therapeutics' (AKBA) Xoanacyl Receives EMA Panel Endorsem - GuruFocus
Akebia says kidney drug endorsed in EU (AKBA:NASDAQ) - Seeking Alpha
EMA panel endorses Akebia’s kidney disease treatment - Investing.com
Akebia Therapeutics EC Will Review CHMP Recommendation, Final Decision Expected In About Two Months - MarketScreener
EMA panel endorses Akebia’s kidney disease treatment By Investing.com - Investing.com UK
Akebia Therapeutics Announces Positive Opinion of European - GlobeNewswire
Major Win for Akebia: EMA Committee Recommends Novel Dual-Action Kidney Disease Treatment - Stock Titan
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Akebia Therapeutics Expands Team with Strategic Stock Options for 8 Key Hires - Stock Titan
AVEROA Receives Positive Opinion from the European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD) - The Manila Times
AVEROA Receives Positive Opinion from the European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD) - GlobeNewswire Inc.
Jefferies Initiates Coverage of Akebia Therapeutics (AKBA) with Buy Recommendation - Nasdaq
Jefferies sets Akebia Therapeutics stock at Buy, $6 price target By Investing.com - Investing.com Canada
Jefferies Initiates Akebia Therapeutics at Buy With $6 Price Target - MarketScreener
Akebia initiated with a Buy at Jefferies - TipRanks
Analysts Love These 2 Growth Stocks That Have Over 200% Upside Potential - MSN
Piper Sandler maintains Akebia stock with $6 price target By Investing.com - Investing.com Canada
Akebia Therapeutics to Present Research at National Kidney Foundation Spring Clinical Meetings 2025 - Nasdaq
Akebia Therapeutics Announces Poster Presentations at NKF Spring Clinical Meetings 2025 - GlobeNewswire
Breakthrough Kidney Disease Treatment Data: Akebia's Vadadustat Shows Promising Results - Stock Titan
Akebia Therapeutics’ $50 Million Common Stock Offering - Global Legal Chronicle
Akebia Stock Drops 28% on Pricing of $50M Common Stock Offering - MSN
Akebia Stock Drops 28% On Pricing Of $50M Common Stock Offering - Barchart
Akebia's Valuation Looks Stretched Despite Auryxia’s Loss Of Exclusivity (NASDAQ:AKBA) - Seeking Alpha
Why Akebia Therapeutics Inc. (AKBA) Went Down On Thursday? - MSN
Akebia Therapeutics Announces $50 Mln Public Offering Of Common Stock - Nasdaq
Akebia Therapeutics Announces Public Offering Pricing - TipRanks
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase - Benzinga
JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Price Is Right But Growth Is Lacking After Shares Rocket 33% - Simply Wall St
Akebia Therapeutics tumbles on deep-discounted $50 mln stock sale - TradingView
Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Akebia Therapeutics Prices $50 Million Public Offering -March 20, 2025 at 04:19 am EDT - Marketscreener.com
Thursday’s 10 Worst-Performing Stocks - Insider Monkey
Akebia Therapeutics Announces Pricing of Public Offering of Common Stock - GlobeNewswire
Akebia Therapeutics Announces Pricing Of Public Offering Of Common Stock -March 19, 2025 at 10:18 pm EDT - Marketscreener.com
Akebia Therapeutics Raises $50M: Major Stock Offering Priced at $2.00 Per Share - StockTitan
‘Buckle Up for Another Surge,’ Says Cowen About Nvidia Stock - The Globe and Mail
Akebia Therapeutics launches public stock offering By Investing.com - Investing.com South Africa
2 No-Brainer Biotech Stocks to Buy Right Now - The Globe and Mail
SEC Form 424B5 filed by Akebia Therapeutics Inc. - Quantisnow
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Akebia Therapeutics announces proposed public offering of common stock -March 19, 2025 at 04:57 pm EDT - Marketscreener.com
Akebia Therapeutics launches public stock offering - Investing.com
Is Akebia Therapeutics (AKBA) the Best Stock to Invest in for a Stock Market Game? - Insider Monkey
Akebia Therapeutics dives on stock offering plans - TradingView
Akebia Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewswire
Akebia Therapeutics Unveils Major Public Offering: Key Details for Investors - StockTitan
Why United Airlines (UAL) Stock Is Trading Up Today - The Globe and Mail
AKBA stock touches 52-week high at $2.48 amid robust gains - Investing.com Australia
2 Large-Cap Stocks with Exciting Potential and 1 to Avoid - The Globe and Mail
Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
9.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):